27.07.2011 • News

Praxair Q2 Profit Rises

Praxair Wednesday said net income in the second quarter increased to $425 million or $1.38 per share from $371 million or $1.19 per share in the prior year.

On average, 16 analysts polled by Thomson Reuters expected the company to earn $1.37 per share in the quarter. Analysts' estimates typically exclude special items.

Sales increased 13% to $2.86 billion from $2.53 billion, surpassing Wall Street view of $2.79 billion.

For the third quarter, Praxair expects earnings per share in the range of $1.35 to $1.40. Analysts expect earnings of $1.39 per share for the quarter.
Further, the company increased its full year earnings guidance to $5.40 to $5.50 per share from the prior range of $5.35 to $5.45.

For 2011, Praxair expects sales in the area of $11.2 billion. The previous projection was for sales in the area of $11 billion.

Wall Street expects 2011 earnings of $5.47 per share on revenues of $11.16 billion.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.